Age Related Macular Degeneration: Disease Bioinformatics
Research of Age Related Macular Degeneration has been linked to Pathologic Neovascularization, Choroidal Neovascularization, Retinal Diseases, Blind Vision, Exudative Age-related Macular Degeneration. The study of Age Related Macular Degeneration has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Age Related Macular Degeneration include Pathogenesis, Aging, Angiogenesis, Localization, Cell Death. These pathways complement our catalog of research reagents for the study of Age Related Macular Degeneration including antibodies and ELISA kits against VEGFA, AMD1, RPE, CFH, ABCA4.
Age Related Macular Degeneration Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Age Related Macular Degeneration below!
For more information on how to use Laverne, please read the How to Guide.
We have 1639 products for the study of Age Related Macular Degeneration that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Age Related Macular Degeneration is also known as age related macular degeneration, age-related macular degeneration, senile macular retinal degeneration, macular degeneration, senile, macular degeneration, amd.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.